By Daniels Porco & Lusardi, LLP | Published March 7, 2024 | Posted in Uncategorized | Comments Off on On March 7, 2024, an LSD formula (MM120) was granted Breakthrough Therapy Status by the FDA
On March 7, 2024, an LSD formula (MM120) was granted Breakthrough Therapy Status by the FDA. According to the FDA, the “Breakthrough Therapy Status” designation requires preliminary clinical evidence that demonstrates the drug may have substantial improvement on at least one clinically significant endpoint over available therapy. This also means the LSD formula has received Read More
Read More